Presentations (slides, Video) and Abstract are available to GBCC Sign-up members.
You can access after log-in.
Previous Meetings
GBCC 2015
Global Breast Cancer Conference 2015
07:30-08:10
Breakfast Symposium 1 (Sponsored by Sanofi-Aventis)
Venue: Halla Hall
-
Adjuvant Non-Anthracycline Regimen in Operable Breast Cancer - Changing the Standard of CareYeesoo Chae (Department of Oncology, Kyungpook National Univ. Medical Center, Korea)
08:30-09:30
Plenary Lecture 3
Venue: Halla Hall
-
Precision Medicine - Implications for Breast Cancer Clinical Trial DesignJo Anne Zujewski (Clinical Investigations Branch, Cancer Therapy Evaluation Program, NIH Clinical Center, U.S.A.)
09:40-10:50
Symposium 3
TNBC (Triple Negative Breast Cancer)
Venue: Halla Hall
-
Current Management of TNBCJoohyuk Sohn (Department of Internal Medicine, Yonsei Univ. Medical Center, Korea)
-
Heterogeneity of TNBCRebecca Dent (Division of Medical Oncology, National Cancer Centre Singapore, Singapore)
-
Subtype-directed Therapy of TNBCRuth M. O’Regan (Division of Hematology/Oncology, Univ. of Wisconsin, U.S.A.)
Symposium 4
Targeted Therapy in Breast Cancer
Venue: Lotus Hall
-
PD1/PDL1 Targeted Immunotherapy in Breast CancerDavid Page (Department of Medicine, Memorial Sloan-Kettering Cancer Center, U.S.A.)
-
PI3K/AKT/mTOR Pathway Inhibitors in Breast CancerYoon Sim Yap (Department of Medical Oncology, National Cancer Centre Singapore, Singapore)
-
CDK 4/6 InhibitorsSudeep Gupta (Department of Medical Oncology, Tata Memorial Centre/Hospital, India)
11:00-12:10
Symposium 5
Hormone Positive Breast Cancer
Venue: Halla Hall
-
Adjuvant Endocrine Therapy in Premenopausal WomenSeigo Nakamura (Department of Surgery, Division of Breast Surgical Oncology, Showa Univ., Japan)
-
Adjuvant Endocrine Therapy in Premenopausal Women in 2015Woo Chul Noh (Department of Surgery, Korea Cancer Center Hospital, Korea)
-
Luminal B Breast CancerGiuseppe Viale (Department of Pathology, IEO Istituto Europeo di Oncologia, Italy)
Symposium 6
Companion Diagnostics
Venue: Lotus Hall
-
Ki-67 Labeling Index in Breast CancerGyungyub Gong (Department of Pathology, ASAN Medical Center, Korea)
-
ER, PR and HER2 Testing in Breast CancerYoung Kyung Bae (Department of Pathology, Yeungnam Univ. Medical Center, Korea)
-
NGS-based DiagnosticsWoong-Yang Park (Samsung Genome Institute, Samsung Medical Center, Korea)
12:10-13:10
Luncheon Symposium 2 (Sponsored by Roche)
Venue: Halla Hall
-
Current and Future Perspectives in Treatment of Metastatic TNBCYeon Hee Park (Department of Hematology-oncology, Samsung Medical Center, Korea)
13:20-14:30
ABRCA
Venue: Lotus Hall
-
Cancer Genetic Risk Assessment in Breast CancerSoo Hwang Teo (Breast Cancer Research Group / Faculty of Medicine, Cancer Research Initiatives Foundation, Malaysia)
-
Clinical Significance of Variants of Unknown Significance (VUS) in BRCA1/2 GenesAva Kwong (Department of Surgery, Queen Mary Hospital, Hong Kong)
-
Risk-reduction Surgery in BRCA Mutation CarriersSung-Won Kim (The Breast & Endocrine Service, Department of Surgery, Daerim St. Mary’s Hospital, Korea)
-
Genetic Counseling in AsiaSeigo Nakamura (Department of Surgery, Division of Breast Surgical Oncology, Showa Univ., Japan)
13:30-14:30
Plenary Lecture 4
Venue: Halla Hall
-
Steps towards Precision Treatment in Breast Cancer: Lessons from Safir01 TrialFabrice Andre (Breast Cancer Unit, Institut Gustave Roussy, France)
14:40-15:50
Symposium 7
Hereditary Breast Cancer
Venue: Halla Hall
-
Management of BRCA1/2 Mutation CarriersSteven Narod (Familial Breast Cancer Research Unit, Women’s College Research Institute, Canada)
-
Characterising Cancer Risks for Carriers of Mutations in BRCA1, BRCA2, PALB2 and RAD51C GenesAntonis Antoniou (Public Health and Primary Care, Univ. of Cambridge, United Kingdom)
-
Absolute Risks and Hormonal/Lifestyle Risk Modifiers among BRCA Mutation Carriers, the IBCCS ExperienceMatti Rookus (Department of Epidemiology, Netherlands Cancer Institute, Netherlands)
Panel Discussion 3
Role of Trustuzumab in Small HER2+ Early Breast Cancer
Venue: Lotus Hall
-
ProsSeock-Ah Im (Department of Internal Medicine, Seoul National Univ. Hospital, Korea)
-
ConsJanice Tsang (Department of Clinical Oncology, Queen Mary Hospital, Hong Kong)
Oral Presentation 2
Venue: Weolla Room
-
[OP2-1] PSYCHOSOCIAL CHARACTERISTICS OF HONG KONG CHINESE FEMALES UNDERTAKING GENETIC COUNSELLING AND TESTING FOR HEREDITARY BREAST AND OVARIAN CANCERSAnnie Tsz-Wai Chu (Department of Breast Surgery, The Univ. of Hong Kong, Hong Kong)
-
[OP2-2] EPITHELIAL-MESENCHYMAL TRANSITION INDUCED BY IL-6/STAT3 PATHWAY ACTIVATION IN RESIDUAL TUMOR PREDICT OUTCOME IN TRIPLE NEGATIVE BREAST CANCER PATIENTS AFTER NEOADJUVANT CHEMOTHERAPYZhengkui Sun (Department of Breast Surgery, Jiangxi Cancer Hospital, China)
-
[OP2-3] COMMON GENETIC VARIANTS ASSOCIATED WITH BREAST CANCER AND A NEW MAMMOGRAPHIC DENSITY MEASURE, CIRROCUMULUS, THAT BETTER PREDICTS DISEASEKevin Nguyen (Centre for Epidemiology & Biostatistics, Melbourne School of Population and Global Health, The Univ. of Melbourne, Australia)
-
[OP2-4] COMPARING STRENGTHS OF BREAST CANCER RISK FACTORS MEASURED ON DIFFERENT SCALES USING ODDS PER ADJUSTED STANDARD DEVIATION (OPERA)John Hopper (Centre for Epidemiology & Biostatistics, Melbourne School of Population and Global Health, The Univ. of Melbourne, Australia)
-
[OP2-5] A PROPOSAL FOR A NEW CLASSIFICATION OF T4 BREAST CANCER AS STAGE IIIC: A REPORT FROM THE KOREAN BREAST CANCER SOCIETYHee Jeong Kim (Department of Surgery, ASAN Medical Center, Korea)
-
[OP2-6] CONCURRENT GnRH AGONIST WITH CHEMOTHERAPY IMPROVE RESPONSE OF NEOADJUVANT CHEMOTHERAPYTaein Yoon (Division of Breast and Endocrine, Department of Surgery, ASAN Medical Center, Korea)
-
[OP2-7] THE IMPACT OF RAS/MAPK/S6K SIGNALING PATHWAY ON PREDICTION OF CLINICAL OUTCOME IN METASTATIC HER2 POSITIVE BREAST CANCER PATIENTS TREATED WITH TRASTUZUMABMarek Svoboda (Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Czech Republic)
-
[OP2-8] FIBROBLAST GROWTH FACTOR RECEPTOR 4 EXPRESSION IS ASSOCIATED WITH RESISTANCE TO DOCETAXEL DURING NEOADJUVANT CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCERJun Ho Lee (Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan Univ. School of Medicine, Korea)
16:00-17:00
Panel Discussion 4
Oncoplastic Surgery for Small Breast
Venue: Halla Hall
-
ProsBarbara Lynn Smith (Division of Surgical Oncology, Massachusetts General Hospital, U.S.A.)
-
ConsAva Kwong (Department of Surgery, Queen Mary Hospital, Hong Kong)
16:00-17:10
Education Session 2
Cancer Genomics
Venue: Weolla Room
-
Understanding of Genomics TechnologyJu-Seog Lee (Systems Biology, MD Anderson Cancer Center, U.S.A.)
-
Overview of Breast Cancer GenomicsJoon Jeong (Department of Surgery, Division of Breast and Endocrine Surgery, Gangnam Severance Hospital, Korea)
16:00-18:00
Nursing Session
Women's Health Care in Breast Cancer
Venue: Lotus Hall
-
Women’s Health Care in Breast CancerSo Young Park (Department of Internal Medicine, Cheil General Hospital, Korea)
-
Managing Menopausal Symptoms among Breast Cancer SurvivorsHye Jin Joh (Seoul St. Mary’s Hospital, Korea)
-
Adopting Self-awareness after Breast TreatmentYoung Ran Yoon (Nursing Department of Woman Cancer Center, Ewha Womans Univ. Mokdong Hospital, Korea)
-
Pregnancy in Young Women with Breast CancerEunkyung Hwang (Breast Care Center, Seoul National Univ. Hospital, Korea)
-
The Role of Oncology Nurse in Sexual ManagementEun-Young Jun (Nursing Department, Daejeon Univ., Korea)
17:00-18:00
Panel Discussion 5
Oncoplastic Surgery: Reconstruction Using Autologous Tissue vs. Artificial Implant
Venue: Halla Hall
-
Autologous TissueKyung Won Minn (Department of Plastic and Reconstructive Surgery, Seoul National Univ. Hospital, Korea)
-
Artificial ImplantYoshiko Iwahira (Breast Surgery Clinic, Japan)
18:00-19:00
Dinner Symposium (Sponsored by Kyowa Kirin)
Venue: Halla Hall
-
Clinical Impacts of Primary Prophylaxis for FN (Febrile Neutropenia) in Breast Cancer PatientsYoung Jin Suh (Breast Surgical Oncology/Surgery, St. Vincent’s Hospital, Korea)